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MALIGNANT melanoma is a disease of antiquity, as shown by the discovery
of melanotic deposits in the bones of pre-columbian Inca mummies (Urtega and
Pack, 1966).
Malignant melanoma is a rare disease. The incidence in South Wales is ofthe
order of 1V6 per 100,000 for females, and 1*4 per 100,000 for males (Cancer
Registration 1960-63). This incidence is similar to the American figure of 1*7 per
100,000 (Beerman et al., 1955) and much lower than the 14-3 per 100,000 quoted
for Australia (Davis and Herron, 1966).
This paper describes the clinical features and value oftreatment, measured by
5-year survival experience and rate of recurrence, for a series of 111 patients
seen in South Wales between the years 1941 and 1961. All of these patients
were Caucasians. In 89, adequate pathological material was available and the
clinico-pathological correlation is reported in the following paper (Williams et al.,
1968).
The clinicalfeatures examined were: sex, age, size, site, palpable regional nodes,
pre-existing lesion, duration ofsymptoms, and the method ofbiopsy.
All the survivors have been followed by interview and by clinical examination,
and only those alive on the 5th (or later) anniversary oftheir treatment have been
included in the survival tables. Survival rates have been calculated from the
time oftreatment ofthe primary disease, and not from the onset ofthe disease as
others have done (Mundth et al., 1965). Though no distinction has been made
between deaths from melanoma and deaths from other causes in the 5-year period,
69 were attributed to melanoma and 4 to other causes.
RESULTS
The overall 5-year survival rate was 34%, including patients alive with and
without recurrent disease. Only one patient was found alive with untreated
recurrentdisease.
Fig. 1 shows that there is an improvement in survival after the 5th year for
both sexes, although a study of 10-year survival was not an objective, and only
16 patients were exposed to risk for this length oftime. At 10 years, the survival
ratewas 27 %.
Clinical Features ofthe Primary Lesion
Sex
Of the 111 patients, 63 (57 %) were female and 48 (43 %) were male. The
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was 52 % females to 48 % males, thus indicating a higher incidence of this disease
amongst females.
Fig. 1 shows the higher survival rate in females. At 5 years the rate was
41 % compared to 250 for males, a difference which, due to the small numbers,
was not statistically significant at a probability level of0.05 (X2 = 2-52, P- 0.11).
After 5 years, however, survival experience is similar for both sexes, a feature well
illustrated by the almost parallel slope of the lines in Fig. 1.
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FIG. 1.-Survival rates after treatment for malignant melanoma.
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The meanl age of males when first seen was 52X7 years, and of females 50@0
years, a difference which could be ascribed to chance. No cases of pre-pubertal
melanoma were seen, and the exact time of the menopause was noted in only a
few patients. The largest group of female patients occurred in the decade aged
45-54 but the relative incidence per 1000 population remained almost constant
between the ages of 25 and 74.
Survival rates by 10 year age groups and by sex showed no significant feature
(Table I). A broader age grouping into "under 55 years'" and "55 and over"
showed a significantly poorer prognosis for older males, only 16 0 surviving
compared with 39 a of females. It can nevertheless be expected that the higher
mortality generally experienced by males at these ages will also be experienced
by melanoma patients, and that mortality from other causes might also exceed
that for females. It so happened that not one of the 4 deaths attributed to other
causes was male.
At ages under 55, there was no significant difference in survival.CLINICAL FEATURES OF SKIN MELONOMA
TABLE I.-Distribution by Age and Sex, with 5-year Survival Rates
5-year survival
r ~~~~A_
Male Female
No. of patients A _ A
A_________ No. Rate No. Rate
. Male Female (%) (%)
4 1 . 1 25 1 100
7 13 2 29 7 54
3 12 . .. .. 4 33
9 14 5 56 5 36
12 9 2 17 3 33
9 10 . 2 22 4 40
4 4 .. .. 2 50
48 63 . 12 25 26 41
Site ofprimary lesion
Tables II, IlIa and IlIb show the site distribution ofthe primary lesions, the
relationship to sex, and the mean age of occurrence.
TABLE II.-Site ofPrimary Lesion by Sex and Mean Age of Occurrence
Site of
primary lesion
Lower limb
Head and neck
Trunk
Upper limb
No primary found
All sites
Males Females Mean age of
r A
. occurrence (in yrs.)
No. of No. of A
patients % patients % Males Females
15 31-3 32 50-8 . 57-3 45*3 S
14 29-2 13 20-6 . 52-1 58-5
13 27-0 8 12*7 . 46-2 51-3
6 12-5 9 14-3 . 56*7 53-3
- 1 1.6 .
48 100 0 63 100-0 . 527 50.0
S = Significant difference between mean age of occurrence in males and females.
Difference: 12 -0 yrs. ± 5 3, t = 2i 26, P < 0 05
TABLE IIIa.-Site ofPrimary Lesion in Males Subdivided into Broad Age Groups
Site
Lower limb
Head and neck
Trunk
Upper limb
All sites
Under 55
A
No. %
5 22
6 26
10 43
2 9
23 100
55 and over All ages
No. % No. %
10 40 . 15 31
8 32 14 29
3 12 . 13 27
4 16 . 6 13
25 100 . 48 100
TABLE IIIb.-Site ofPrimary Lesion in Females Subdivided into Broad Age Groups
Site
Lower limb
Head and neck
Trunk
Upper limb
All sites
Under 55 55 and over All ages
r
A A
No. % . No. % No. %
26 67 . 6 26 . 32 52
4 10 . 9 39 13 21
5 13 . 3 13 . 8 13
4 10 . 5 22 . 9 14
39 100 . 23 100 . 62* 100
* 1 case where site of the primary lesion was not known has been excluded.
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Group
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35-
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55-
65-
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The commonest site ofmelanoma in both sexes is the lower limb. For females
the proportion is as high as one half of all cases (Table II). It was also apparent
that the mean age of occurrence in the lower limb in females is different in two
distinct ways:
1. A significant difference in the age ofoccurrence between males and females,
females being affected on the average at 45 years, and males 12 years later.
2. A significant difference, when females are considered alone, between the
average age when the lower limb is affected, and the age when other sites
are affected-45-3 years compared with 54-8 for all other sites combined
(difference 9 5 years ± s.e. 3.9).
A further relationship was sought between the site of the lesion, and the age
of the patient according to broad age groups, and this was considered separately
for both males and females (Tables IIIa and IIIb). No significant difference
in incidence could be demonstrated for male patients (Table IIIa), although
melanoma on the trunk was more frequent in the lower age group, and when this
site was compared with all other sites combined, a significant difference was shown
(X2 - 4-5, n = 1, P = 0.03).
For females, (Table IIIb), the difference in incidence between sites, accounted
for mainly by a high incidence on the lower limb in younger women, and on the
head and neck in older women, was significant (x2 = 11X7, P < 0.01). Two thirds
ofall melanomas in women under 55 are on the lower limb in contrast to the other
three sites where there are higher proportions at the older ages.
The proportion on the head and neck site is significantly higher at the older
ages, and among older women as a group this site is more likely to be affected.
To summarise theemergent pointsfrom sub-divisionofsiteincidence byageand
sex, thefollowing are significant:
1. In the young male, lesions of the trunk predominate.
2. In the young female, lesions of the lower limb predominate.
3. In the older female, head and neck lesions are commonest.
The results obtained when the site of the tumour was related to survival rate
are shown in Table IV.
TABLE IV.-5-Year Survivors (per 100) by Sex and Site ofLesion
5-year survivors
No. of patients
A
A_Males Females Both
Site of Lesion Males Females Sexes
Lower limb . 15 32 . 6 (40%) 15 (47%) 45%
Head and neck . 14 13 . 4 (29%) 5 (38%) 33%
Trunk . 13 8 . 1 ( 8%) 3 (38%) 19%
Upper limb . 6 9 . 1 (17%) 3 (33%) 27%
All sites . 48 62* . 12 (25%) 26 (42%) 35%
* 1 female patient for whom site of primary lesion was unknown has been excluded.
Lesions ofthe lower limb carried the best prognosis for both males and females,
and the next most favourable survival rates were experienced by patients with
head and neck lesions. Prognosis was particularly bad for patients with lesionsCLINICAL FEATURES OF SKIN MELANOMA
of the trunk, and at this site a sex difference was apparent, although this might
have occurred by chance (X2 = 1.25, P = 0.26). Only 1 male patient out of 13
survived 5 years.
Whenthe survival datafor allsites were sub-divided into younger and older age
groups, the numbers were too small to permit valid conclusions, but older male
patients (55+) formed a very poor group. Among 7 patients with lesions on
the trunk and upper limbs, none survived, and only 1 out of 10 with lesions
on the lower limb was alive at 5 years.
Size of the primary lesion8 whenfirst seen
The size of the lesion was accurately recorded to the nearest centimetre in
79 (71 %) of the cases. For the purpose of the analysis an arbitrary grouping of
under 3 cm. and 3 cm. and over was made. The distribution of size by sex
(Table V), suggests that the majority of patients, particularly females, are seen
before the lesion has grown to a size of 3 cm.
TABLE V.-5-Year Survival Rate by Size ofLesion and Sex
Males Females Total
No. of Rate No. of Rate No. of Rate
Size of lesion patients Survivors (%) patients Survivors (%) patients Survivors (%)
Under 3 cm. 20 8 40 37 20 54 57 28 49
3 cm. and over 14 1 7 8 1 13 22 2 9
Not known 14 3 21 18 5 28 32 8 25
Total 48 12 25 63 26 41 111 38 34
Almost one half (49 %) ofpatients withlesions less than 3 cm., and only 9 % of
those 3 cm. and over survived for 5 years (X2 = 13-0, n = 2, P <O001-significant
difference). Sex does not modify the result.
The relationship between size, site and sex was examined, but the breakdown
resulted in groups too small to be ofvalue. One point of interest was that of 26
patients who had lesions < 3 cm. on the lowerlimb, 16 or 62 % survived, compared
to all other sites (where 39 % survived). This supports the finding that patients
with lesions on the lower limb have a better than average prognosis.
State of the lymph nodes
According to the degree ofspread, the disease was divided into three stages.
Stage 1-Primary lesion alone.
Stage 2-Primary lesion together with clinical involvement ofdraining nodes.
Stage 3-Primary lesion together with widespread disease, with presence or
absence ofinvolvement of draining nodes.
Ofthe 111 patients, 83 (75%) were Stage 1, while 22 (20 %) were Stage 2 at the
time ofinitial presentation, ofwhom 12 were male and 10 were female. Assessed
by this criterion, there were no cases in Stage 3, and 6 were not known.
Eighty-eight per cent ofpalpable clinically involved nodes showed histological
evidence of tumour.
The difference in 5-year survival rate between Stages 1 and 2, 41 % and 18 °,
was not statistically significant (X2 = 3.0, P = 0-08). The difference between the
two groups in females was not marked (47 % and 30%), but in males there was a
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greater difference (3200 and 8 0). On these data, however, neither difference
reached the 0.05 significance level.
Since prophylactic block dissection was performed on only two occasions, we
were in no position to judge the degree of histological involvement of clinically
negative nodes.
An attempt was made to correlate the presence ofclinically enlarged nodes with
the features ofthe primary lesion. Age and sex had no influence, nor surprisingly
did the duration ofsymptoms. When the nodes were clinically negative, 3400 had
a history of less than 6 months, compared with 45 00 in the clinically positive
group.
The only significant feature of the primary lesion which had an effect on the
clinical involvement of nodes, was the size of the lesion (Table VI). When the
nodes were enlarged 45-50% of the lesions were larger than 3 cm., but when the
nodes were impalpable, only 14-5 00 were larger than 3cm. (X2 - ll.8S n - 2,
P < 0.01).
TABLE VJ.-Relationship of Clinical State of Lymph Nodes with Size of Lesion
Palpable nodes 22 patients > 3 cm. -10 (45.50/)
< 3 cm. 6 6(27 30)
Unknown 6(27-3%)
Total 22
Impalpable nodes 83 patients > 3 cm. 12 (14-5%)
< 3 cm. 51 (61 4%)
Unknown -20 (24 l1o)
Total 83
State of lymph nodes not noted in 6 patients.
Pre-existing lesion
A pre-existing lesion was present in 63 patients, 24 males and 39 females. It
was absent in 36 and unknown in 12. Common manifestations of the onset of
malignant change were ulceration, increase in size, and bleeding. More than one
of these changes was noted simultaneously in 49 patients, so that correlation of
survival with any one feature was not possible. Ulceration was expected to show
a bad prognosis, but the overall survival rate for patients with ulceration was
2700, a rate not much lower than the overall one of 3400.
Taken as a whole, the presence or absence of a pre-existing lesion did not alter
the prognosis. In the absence of a previous lesion, there was very little difference
in survival between the sexes, but an unfavourable rate of 21 00 for males against
46 0/ for females was shown for those with a previous lesion. Though not statis-
tically significant (X2= 3*1, P = 0.08) the result is suggestive and could well be
significant in a larger series.
Duration of symptoms
An attempt was made to assess the duration of symptoms before treatment.
Forty-five per cent of patients presented with a history of less than 6 months,
and 7500 with one of less than 12 months. No difference in length ofhistory was
found between the sexes.
Survival rates appear to be related to the duration of symptoms, but only in a
paradoxical manner, the longer duration of symptoms being associated with aCLINICAL FEATURES OF SKIN MELANOMA
better survival. Thus, when the history was less than 6 months, the survival
rate was 28 %, 6 to 11 months-32 %, 12-23 months-44 %, and 2 years or more
-46%.
Method of biopsy
This was studied in order to assess the importance of local interference. Of
the 111 patients, 18 had had incisional biopsy, i.e. a small area of tumour taken
for biopsy. Thirteen were in Stage 1 and 5 in Stage 2; 11 were female and 7 male.
Most of the lesions were on the head and neck. Following the biopsy, 14 had
further more extensive surgery within a few days and 4 had radiotherapy alone.
There were 6 (33 %) 5-year survivors, similar to the overall survival rate for the
series, and further, there was not an increased incidence oflocal recurrence.
Treatment of the Primary Disease
Treatment depended on the stage of disease, the patients being distributed as
follows. Five ofthe 6 patients not staged according to degree ofspread were here
allocated to Stage 1 and one to Stage 3.
Stage 1-88 patients
Stage 2-22 patients
Stage 3-1 patient
Treatment ofpatients in Stage 1 (Table VII)
Local excision.-In only a third of cases was accurate information available
as to the exact lateral extent oflocal excision, and in only a slightly greaternumber
the deep extent of the excision, i.e. removal of deep fascia. We were, therefore,
in no position to assess with any great precision the importance of wide three-
dimensional removal. We had to follow the indirect method as advocated by
Cade (1961) and assume that direct suture of a wound indicated in most cases an
inadequate removal, while a grafted wound showed that wide removal had been
attempted.
TABLE VII.-Treatmentfor Stage 1 Melanoma
5-Year survival
Method of treatment No. patients rate (%)
Local exci8ion
(a) with direct suture . 43 . 32 5
(b) with split skin graft . 21 . 57
Local exci8ion, with prophylactic nodal
di88ection in continuity . 2 . 100
Amputation
(a) of digit . 7 . 43
(b) below knee . 2 . 50
Radiotherapy
(a) alone . 4 . 50
(b) with surgery . 5 . 40
Inadequate treatment
e.g. diathermy, burnt or . 4 . 25
scratched off
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Prior to 1953, 24 % had skin grafting, while during the second half of the
survey there was an increase to 44 %.
Comparison was therefore made between the 2 types of wound closure and
the results showed an increased survival, 57 % compared to 32-5 %, in the patients
having their wounds closed by grafting. The difference was not significant on the
small numbers ofthis series. There was, however, a significant difference between
these 2 groups in the incidence oflocal recurrence and this will be discussed later.
The information available as to the removal of deep fascia was scanty, but
its removal appeared not to influence the survival rate, or the incidence of local
recurrence.
Local exci8ion with prophylactic removal of regional nodes.-The policy in
Cardiff has been to remove regional nodes only when they became clinically
enlarged. Only 2 patients had prophylactic nodal dissection, one in continuity
andtheothernot. Inboth cases thenodeswerefoundto behistologically negative
and both survived 5 years.
Amputation.-Digits were removed mainly for sub-ungual lesions, of which
there were 4 (3-6 %). The 2 below knee amputations had to be performed for very
large fungating lesions and these were the only examples of major amputative
surgery carried out on patients graded as Stage 1.
Radiotherapy.-It is widely believed that melanomas are radio-resistant. In
this series 4 patients were treated by radiotherapy alone following histological
proof by incisional biopsy. Table VII shows that the results were satisfactory.
All were lesions of the head and neck where surgery had been contra-indicated
on cosmetic grounds.
Radiotherapy as an adjuvant to surgery was performed in 5 patients with a
40Y. 5-year survival. In 4 patients it was given to the primary site alone, while
in the fifth it was given prophylactically to the regional nodes as well.
Inadequate treatment.-Four cases had gross interference to their primary
lesion in the form of diathermy, CO2 snow, silver nitrate, and one lesion was
scratched off, before adequate local therapy had been given. Surprisingly, one
person survived 5 years.
Treatment ofpatients in Stage 2 (Table VIII)
The number of patients presenting in Stage 2 at the initial examination was
22 and after treatment 4 (18 %) survived 5 years.
TABLE VIII.-Treatmentfor Stage 2 Melanoma
No. of 5 year
Type of treatment patients survivors
Amputation
(a) of digit and block dissection . 1 . 0
(b) Hindquarter . 4 . 1
(c) Forequarter . 1 . 0
Radiotherapy
to primary and nodes . 2 0
Local excision
(a) with block dissection . 13 . 2
(b) with block dissection and
radiotherapy . 1 . 1
Total . 22 . 4 (18%)CLINICAL FEATURES OF SKIN MELANOMA
The usual form of therapy in this group was local excision of the primary
followed by block dissection ofthe regional nodes. In 5 cases, major amputative
surgery was performed and no patients were treated with radiotherapy alone.
Treatment and Clinical Features of Recurrent Disease
Of the 111 patients 77 were later treated for recurrent disease (Table IX).
There were 39 males and 38 females. Unless otherwise statedresults inthis section
are based on first recurrence.
TABLE IX.-Classification of Recurrent Disease According to Site
No. of
Site patients Male Female
1. Local recurrence . 21 (27%) . 7 . 14
2. Local and nodal recurrence . 3 (4%) . - . 3
3. Nodal recurrence . 32 (42%) . 18 . 14
4. Widespread recurrence . 21 (27%) . 14 . 7
Total . 77 (100%) . 39 . 38
Local recurrences were defined as those occurring at or near the site ofprimary
excision. " In transit " metastasis or satellitosis was included in groups 1 and 2
in Table IX. If there were local recurrences together with evidence of disease
elsewhere, apart from the nodes, the disease was classified as being widespread.
It was found that most recurrences occurred within a short time ofremoval of
theprimarylesion; 74 % occurredwithin 1 year, and 88 %within 2 years ofremoval
ofthe primary. Fig. 2 summarises the relationship between the site ofrecurrence,
its time of onset, and the eventual survival after treatment. Local and nodal
recurrences usually occurred within 12 months oftreatment ofthe primary, while
widespread disease occurred after an average interval of 25 months.
The commonest site forrecurrent disease was inlymphnodes. Some difference
between the sexes was apparent at each site but was most marked in the presence
ofwidespread recurrence where males were more frequently affected.
LOCAL RECURRENCE
7 Months 22 Months
NODAL RECURRENCE
10 Months 12 Months
WIDESPREAD RECURRENCE
25 Months 4 Months
I 6 12 18 24 30 36
TREATMENT TM NMNH
PRIMARY T I MEIN MONTHS
FIG. 2.-Relationship between " free interval " and survival following treatment of recurrence.
" Free interval "
Survival following treatment C1
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When the site of the primary was considered, it was found that lesions of the
trunk were less prone to spread via the nodal route, local and widespread disease
predominating, but the difference was not significant.
The effect of treatment of primary lesion on the type of recurrent disease is
summarised in Table X. When dealing with local recurrences only, there was a
TABLE X.-Effect ofTreatment of the Primary on Subsequent
Recurrence (all Episodes)
Site of Direct Not
recurrence Excision suture Graft known Total
Local . 3 19 3 . 7 . 32
Nodal . 12 . 22 . 12 . 5 . 51
Widespread 16 . 29 . 11 . 7 . 63
Not known . 2 . 1 . 2 . 1 . 6
Total recurrences . 33 . 71 28 20 . 152
Number of patients 26 . 49 . 28 . 8 111
Overall recurrence
rate per person . 1-27 . 145 . 100 . 2-50 1-37
significantly higher rate ofrecurrence in patients who had their wounds closed by
direct suture rather than by grafting (X2 = 5*6, P < 0.01). There seemed to be
no relationship between the type of wound closure and the frequency of nodal or
widespread recurrence. The inclusion ofdeep fascia in the excision had no effect.
Local recurrence.-The treatment of the 21 patients with locally recurrent
disease is summarised in Table XI. It can be seen that surgery took the form of
TABLE XI.-Treatment ofLocally Recurrent Disease and Survival
No. of 5-year
Treatment patients survivors
Local excision only . 11 . 2
, ,,91+ radiotherapy . 1 -
,, ,91 + chemotherapy. 1
Amputation, below knee . 2
Radiotherapy alone . 3
No treatment or unknown
treatment . 3 . 1
Total . 21 . 3 (14%)
local excision or amputation. Six had further local recurrence, 7 had nodal
recurrence, and 8 (including the 3 untreated cases) died of widespread disease.
Therefore 13 patients out of 21 were suitable for futher surgical treatment.
Local and nodal recurrence.-The 3 patients (Table IX) were treated as follows:
1 had local removal followed by block dissection; 2 had radical surgery, 1 a hind-
quarter, and the other a forequarter, and both are alive and well 15 years later!
Nodal recurrence.-Table XII summarises the treatment given to the 32
patients. The survival in patients who have their nodes dissected only when they
become clinically enlargedis low, only 12 % survived for 5 years. Afurther follow-
up of these 32 patients after treatment showed that the next recurrence took the
form of widespread disease in 26. In only 6 patients (2 with local, and 4 with
nodal) was further surgery possible.
Widespread recurrence.-Chemotherapy was mainly given in the form of
nitrogen mustard, and one patient had her pituitary removed. No form of
treatment seemed to be of use at this stage.CLINICAL FEATURES OF SKIN MELANOMA
TABLE XII.-Treatment ofNodal Recurrence and Survival
No. of 5-year
Treatment patients survivors
Block dissectiom . 21 . 3
,, ,, + radiotherapy . 2
9,, ,,' + cytotoxic agents . 2
Hindquarter amputation . 2 . 1
Radiotherapy alone . 2
Unknown . 3
Total . 32 . 4 (12%)
Two other aspects of recurrent disease need to be discussed, namely
satellitosis and major amputation.
Satellitosis.-This was defined as secondary deposits occurring in the lymphatic
drainage of a primary lesion, and due to lymph stasis, the latter being due to
either deposits oftumour in lymph nodes or to removal ofregional nodes. There
were only 7 patients in this series, an incidence of 6 %. The nodes were clinically
involved in 4, and the other 3 became positive on follow-up. Satellitosis, it is
said, is always a danger when positive nodes are removed, but in our series only 2
out of32developed this complication. Whenthenodes wereinvolved the patients
were far more likely to die of widespread disease.
Major amputation.-Major amputative surgery in this disease (Table XIII)
gives survival rates which compare favourably with that for the whole series. The
number of cases is too small to assess the value ofthis form ofsurgery.
TABLE XIII.-Survival after Various Types of Major Amputative Surgery
Type of No. of 5-year
Stage of disease amputation patients survivors
Primary
Stage 1 . below knee . 2 . 1
Stage 2 . hindquarter (4) 5 . 1 forequarter (l1)
18t Recurrence
Local . below knee . 2 -
Local and Nodal hindquarter 2 2 forequarter 2
Nodal hindquarter . 2 . 1
2nd Recurrence
Nodal . hindquarter . 1
Total . . 14 . 5 (36%)
DISCUSSION
Our overall survival rate of 34% is comparable with recent reports, 41 %,
Wright et al. (1953), 39-1 %, Pack (1959), 40 %, Cade (1961), 32%, James (1961),
40%, Watson (1964). Earlier reports showed a poorer prognosis, 111 %, Affleck
(1936), 18-3 % Daland and Holmes (1939) and 9-7 % Raven (1950). In our series
extending from 1941-61 we found no significant improvement in survival rates
over these years.
Cade (1961) and Watson (1964) stress that due to the frequency of late
recurrences survival analysis should be based on follow up periods greater than
5 years. We agree with Wright et al. (1953) and Vogler et al. (1958) that the
majority of recurrences occur in the first 5 years (88 % in 2 years in our series),
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which justifies our usage of 5 years survival data, and that the 2-year survival
rate-which includes 88 % of the recurrences-would be a valuable index of the
efficiency of a method oftreatment.
Malignant melanoma has never been classified as an endocrine-dependant
tumour (Huggins, 1965) though there are some features to suggest that its bio-
logical activity may be related to the endocrine system. We found a 1P3: 1 female
to male ratio which, in this small sample, varied considerably within age groups.
Nitter (1956) reported a high incidence in menopausal patients with associated
low survival, but the survival rate of our patients in the age range 45-54 was not
markedly lower than that in other age groups. It is universally accepted in
melanoma that survival rates are significantly higher in the female, though White
(1959) has stressed that a survival over 5 years is needed before this becomes
apparent. In our series the difference in survivorship between females and males
became apparent during the first 5 years, and at 5 years, though not statistically
significant was most pronounced, and then remained constant (Fig. 1).
We were unable to show any statistical difference in survival rates between the
age decades with the exception ofolder males, who had a decreased survival rate.
Block and Hartwell (1961) have shown that in contrast to other tumours there is
decreasing survival with age. Wright et al. (1953) emphasised the high survival
rate of young female patients.
The size of the lesion has a profound effect on prognosis, only 9% of patients
with lesions larger than 3 cm. surviving 5 years (compared to 49% with lesions
smaller than 3 cm.). Lesionsofcomparable size seemed to carry a betterprognosis
when situated on the lower limb. Pack et al. (1952) have attributed this to the
uniform lymphatic drainage of this site. The lower limb, and head and neck
lesions have a good prognosis and the predominance of lesions at these sites
amongst younger and older women respectively, might account for the failure
of age to decrease survival in the female. Lesions of the trunk carry a poor
prognosis which has been attributed to its diffuse lymphatic drainage.
Mundth et al. (1965) showed that with equal duration ofsymptoms there was a
much higher percentage of males presenting with enlarged regional nodes. This
suggests that the disease is more active in the male. This could not be demon-
strated though there were certain features to suggest that the disease was
biologically less active in the female, viz:
(a) They presented with smaller lesions.
(b) When the melanoma arose from a pre-existing lesion the survival rate was
greater for females than for males.
(c) The difference in survival between patients with palpable and impalpable
nodes was less marked in the female.
Lea (1965) has emphasised the role of trauma as an aetiological factor. We
felt like others (Catlin, 1954; Cade, 1961) that it only served to draw attention to a
lesion already undergoing malignant change.
We found that incisional biopsy and gross interference with the primary
lesion did not appreciably alter the survival or recurrence rate. This is probably
accounted for by the small numbers in the series, and we felt that any interference
is best avoided.
We would advocate that the primary should be treated by wide removal of
the skin and subcutaneous tissue followed by split skin grafting. FollowingCLINICAL FEATURES OF SKIN MELANOMA
such treatment we found that the incidence of local recurrence is significantly
reduced. Our results show that removal of deep fascia had no effect on survival.
Olsen (1966) found that removal of deep fascia increases the spread to regional
nodes by destroying a system of lymphatic valves, and he showed by lymphangio-
graphic techniques that these valves direct lymph superficially from the deep
fascia, and not towards it as was thought previously (Handley, 1907).
The value of radiotherapy has been underestimated, and Cade (1961) has
drawn attention to the work of Ellis (1939) who successfully treated 38 patients
with D.X.R. alone. Two of 4 of our patients treated only by D.X.R. survived 5
years. Nitter (1956) and Dickson (1958) have shown that the results from
surgery alone can be improved by prophylactic, post-operative radiotherapy to
the operative site and/or to the regional nodes. In our 5 patients treated in this
way, 2 survived 5 years. We would therefore disagree with the statement that
"Malignant melanoma is as resistant as the surrounding skin " (Wright et al.,
1953).
Even though Handley in 1907 wrote
"the problem is not the excision of an
organ, but the extirpation of a diseased lymphatic area ", we are still doubtful how
far to extend surgical excision. In only 2 cases was prophylactic nodal dissection
performed, both survived for 5 years and had histologically negative nodes. In
such cases with clinically negative nodes 20-50 % will be found to have histological
involvement (Fortner et al., 1964).
The low 12 % 5-year survival rate in this series following therapeutic nodal
dissection is fairly representative (Fortner et al., 1964). It suggests that the
removal of nodes before they become involved would improve survival. Spread
to regional nodes is the commonest form of metastasis in this series. Recent
anatomical studies by Pressman and Simon (1961), show that direct communica-
tions exist between lymph nodes and the venous system, allowing the passage of
fluid, cells and air. This would explain our finding of over 800/ of patients with
recurrent nodal disease dying of widespread involvement within a short period of
time, and would indicate that the disease is at an advanced stage when regional
nodes become involved. Removal ofthese nodes at an early stage might therefore
remove an important pathway of spread. However, despite the overwhelming
evidence for prophylactic nodal dissection in some series (Mundth et al., 1965)
others disagree (Sandeman, 1966; McNeer and Das Gupta, 1964), and the case
still remains to be proven.
In many cancers, e.g. carcinoma of the breast, the length of the so-called
"free interval between treatment and recurrence is one of the most important
clinical indications in assessing further survival. In cases of malignant melanoma
with recurrence we found, to our surprise, that the shortest free interval was
associated with the best prognosis and this occurred in locally recurrent disease
(Fig. 2). The long
"free-interval ", and then the rapid lethal effect of widespread
involvement is similar to the classical description in ocular melanoma by Wilbur
and Hartman (1931). The length of the
"free-interval for nodal recurrent
disease falls between that for local and widespread recurrent disease.
The average length of survival in each type of recurrent disease was approxi-
mately the same (Fig. 2) and would suggest that the biological activity of this
tumour may be pre-determined and that consequently treatment may have
little effect on the eventual outcome. Yet we were impressed by the value of
radical surgery at all stages of the disease, and particularly the value of major
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amputative surgery (Table XIII). McPeak et al. (1963) gave a survival rate of
30% for major amputative surgery which is similar to our figure of 3600.
SUMMARY
A retrospective study of 111 patients with malignant melanoma of the skin,
seen in South Wales between the years 1941-1961 is described. The overall
5-year survival rate was 34 %.
1. The series included a slight excess of females and though not significant,
the survival rates were generally higher in females.
2. Lesions occurred most frequently in the lower limb followed by head
and neck site, trunk, and upper limb. The order was subject to reversal by the
influence of age and sex. Lesions of the lower limb were most frequent among
younger females, head and neck among older females and trunk among younger
males.
3. At the lower limb the average age ofoccurrence in females was 45 years and
in males 12 years later. This low average age for females also contrasted with the
age at which they were affected at other sites-an average of 91 years later.
4. Lesions of the lower limb carried the best prognosis for both males and
females, followed by head and neck lesions, upper limb and trunk. Lesions of
the trunk resulted in a low rate ofsurvival particularly among males and a further
vulnerable group was that of older males, irrespective of site of lesion.
5. In females the disease presented as smaller lesions than in males. Small
lesions (< 3 cm. in diameter) in both sexes showed a longer survival period than
larger lesions (> 3 cm. in diameter).
6. In both sexes, the incidence of nodal metastasis was similar and decreased
the survival rate. The effect was less marked in females.
7. The duration ofsymptoms was directly related to survival, long duration was
associated with better prognosis.
8. Treatment: the best survival followed wide local excision of the primary
lesion, surrounding skin and subcutaneous tissue. The removal of deep fascia
did not affect survival. A uniformly low survival rate followed therapeutic
nodal dissection. Our evidence suggests that prophylactic nodal dissection
might well improve prognosis.
9. Radiotherapy alone is of some value in a few selected cases of head and
neck lesions. It was found impossible to assess the value of radiotherapy,
ablative hormone therapy and chemotherapy as adjuvants to surgery.
10. 88 % of recurrent disease occurred within the first 2 years following treat-
ment. Five-year survival rates were therefore of value in assessing prognosis.
11. The length of the so-called " free-interval " was found to be inversely
related to survival time and of little value on its own in assessing prognosis.
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